查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1547380

全球外泌体技术市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Exosome Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2032年，全球外泌体技术市场的市场规模将从2023年的6,642万美元达到近5,1004万美元，2024-2032年研究期间复合年增长率为25.42%。

外泌体技术专注于外泌体的利用，外泌体是细胞释放的小细胞外囊泡，在细胞间通讯中发挥不可或缺的作用。这些囊泡携带蛋白质、脂质和遗传物质，影响各种生理和病理过程。它包括它们的分离、表征以及在诊断和治疗中的应用。在诊断中，外泌体可以作为癌症和神经退化性疾病的生物标记。治疗方法被探索用于药物输送和再生医学，因为它们可以将治疗分子输送到特定的目标细胞。这些技术的进步为个人化医疗和新颖的治疗策略带来了希望。

市场动态

人们对外泌体在诊断和治疗方面的潜力越来越感兴趣，这正在推动外泌体技术市场的成长。外泌体作为生物分子的天然载体，提供了一种非侵入性的疾病检测和监测手段，在癌症诊断和其他医学领域尤其有价值。分离和表征技术的进步提高了基于外泌体的应用的功效和可靠性，进一步推动了市场成长。慢性病负担的增加以及对有效治疗方案的需求也促进了市场的成长。此外，生物技术公司和研究机构对研发的大量投资正在加速创新并扩大外泌体产品的潜在应用。监管部门的批准和对临床试验的支持为外泌体技术的商业化提供了有利的环境。人们越来越关注个人化医疗，即基于外泌体的诊断和治疗可以根据个别患者的情况进行客製化，这是推动市场成长的另一个因素。此外，外泌体由于能够跨越生物屏障运输治疗剂，在药物递送系统中的潜力引起了人们的广泛关注和投资，从而促进了外泌体技术市场的强劲增长。然而，大规模生产、隔离技术标准化和监管审批流程的挑战可能会阻碍未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球外泌体技术市场的各个细分市场进行了包容性评估。外泌体技术产业的成长和趋势为本研究提供了整体方法。

市场区隔

外泌体技术市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按外泌体类型

  • 装载货物（胜肽、SIRNA、mRNA、miRNA、蛋白质、化学物质、其他）
  • 非货物

按细胞来源

  • HEK293细胞
  • 间质干细胞
  • 血小板
  • 红血球
  • 自然杀手细胞
  • 其他的

按申请

  • 治疗学（肿瘤学、神经退化性疾病、心血管疾病、传染病、化妆品、其他）
  • 诊断

按最终用户

  • 医疗保健提供者
  • 製药与生物技术公司
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲外泌体技术市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。外泌体技术市场的主要参与者包括Aegle Therapeutics、Aruna Bio Inc.、Bio-Techne Corporation、Carmine Therapeutics Inc.、Codiak BioSciences Inc.、Creative Biolabs、Danaher Corporation (Beckman Coulter Inc.)、Fujifilm Holdings Corporation、NOVADIP Biosciences SA 、OmniSpirant Limited、Thermo Fisher Scientific Inc。以及其他进展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：外泌体技术 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 外泌体类型的市场吸引力分析
    • 按细胞来源分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球外泌体技术市场分析：按外泌体类型

  • 按外泌体类型概述
  • 依外泌体类型进行历史和预测数据分析
  • 装载货物（胜肽、SIRNA、mRNA、miRNA、蛋白质、化学物质、其他）
  • 非货物

第 6 章：全球外泌体技术市场分析：依细胞来源分类

  • 按细胞来源概述
  • 按细胞源进行历史和预测数据分析
  • HEK293细胞
  • 间质干细胞
  • 血小板
  • 红血球
  • 自然杀手细胞
  • 其他的

第 7 章：全球外泌体技术市场分析：依应用分类

  • 概述：按应用
  • 历史与预测资料分析：按应用分类
  • 治疗学（肿瘤学、神经退化性疾病、心血管疾病、传染病、化妆品、其他）
  • 诊断

第 8 章：全球外泌体技术市场分析：依最终使用者分类

  • 最终用户概述
  • 最终用户的历史和预测数据分析
  • 医疗保健提供者
  • 製药与生物技术公司
  • 其他的

第 9 章：全球外泌体技术市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：外泌体技术公司的竞争格局

  • 外泌体技术市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Aegle Therapeutics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Aruna Bio Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bio-Techne Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Carmine Therapeutics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Codiak BioSciences Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Creative Biolabs
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Danaher Corporation (Beckman Coulter Inc)
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Fujifilm Holdings Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • NOVADIP Biosciences SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • OmniSpirant Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11215742

The global demand for Exosome Technologies Market is presumed to reach the market size of nearly USD 510.04 Million by 2032 from USD 66.42 Million in 2023 with a CAGR of 25.42% under the study period 2024-2032.

Exosome technologies focus on the utilization of exosomes, which are small extracellular vesicles released by cells that play an integral role in cell-to-cell communication. These vesicles carry proteins, lipids, and genetic material, influencing various physiological and pathological processes. It encompasses their isolation, characterization, and application in diagnostics and therapeutics. In diagnostics, exosomes can be biomarkers for cancer and neurodegenerative disorders. Therapeutics are explored for drug delivery and regenerative medicine, as they can deliver therapeutic molecules to specific target cells. Advances in these technologies hold promise for personalized medicine and novel treatment strategies.

MARKET DYNAMICS

The increasing interest in exosomes for their potential in diagnostics and therapeutics is driving the growth of the exosome technologies market. Exosomes, as natural carriers of biomolecules, offer a non-invasive means of disease detection and monitoring, which is particularly valuable in cancer diagnostics and other medical fields. Advancements in isolation and characterization techniques enhance the efficacy and reliability of exosome-based applications, further propelling market growth. The rising burden of chronic diseases and the need for effective treatment options also boost market growth. Furthermore, significant investments in research and development by biotech companies and research institutions are accelerating innovations and expanding the potential applications of exosome-based products. Regulatory approvals and support for clinical trials provide a conducive environment for the commercialization of exosome technologies. The increasing focus on personalized medicine, where exosome-based diagnostics and therapeutics can be tailored to individual patient profiles, is another factor driving market growth. Additionally, the potential of exosomes in drug delivery systems, due to their ability to transport therapeutic agents across biological barriers, garners significant attention and investment, contributing to the robust growth of the exosome technologies market. However, challenges in large-scale production, standardization of isolation techniques, and regulatory approval processes may hinder market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Exosome Technologies. The growth and trends of Exosome Technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Exosome Technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Exosome Type

  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others)
  • Non-cargo

By Cell Source

  • HEK293 Cells
  • MSCs
  • Platelets
  • Erythrocytes
  • Natural Killer Cells
  • Others

By Application

  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others)
  • Diagnostics

By End-user

  • Health Care Providers
  • Pharmaceutical & Biotechnology Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Exosome Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Exosome Technologies market include Aegle Therapeutics, Aruna Bio Inc., Bio-Techne Corporation, Carmine Therapeutics Inc., Codiak BioSciences Inc., Creative Biolabs, Danaher Corporation (Beckman Coulter Inc), Fujifilm Holdings Corporation, NOVADIP Biosciences S.A., OmniSpirant Limited, Thermo Fisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EXOSOME TECHNOLOGIES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Exosome Type
    • 3.7.2 Market Attractiveness Analysis By Cell Source
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY EXOSOME TYPE

  • 5.1. Overview By Exosome Type
  • 5.2. Historical and Forecast Data Analysis By Exosome Type
  • 5.3. Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Historic and Forecast Sales By Regions
  • 5.4. Non-cargo Historic and Forecast Sales By Regions

6. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY CELL SOURCE

  • 6.1. Overview By Cell Source
  • 6.2. Historical and Forecast Data Analysis By Cell Source
  • 6.3. HEK293 Cells Historic and Forecast Sales By Regions
  • 6.4. MSCs Historic and Forecast Sales By Regions
  • 6.5. Platelets Historic and Forecast Sales By Regions
  • 6.6. Erythrocytes Historic and Forecast Sales By Regions
  • 6.7. Natural Killer Cells Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Historic and Forecast Sales By Regions
  • 7.4. Diagnostics Historic and Forecast Sales By Regions

8. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY END-USER

  • 8.1. Overview By End-user
  • 8.2. Historical and Forecast Data Analysis By End-user
  • 8.3. Health Care Providers Historic and Forecast Sales By Regions
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL EXOSOME TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EXOSOME TECHNOLOGIES COMPANIES

  • 10.1. Exosome Technologies Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF EXOSOME TECHNOLOGIES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Aegle Therapeutics
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Aruna Bio Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bio-Techne Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Carmine Therapeutics Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Codiak BioSciences Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Creative Biolabs
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Danaher Corporation (Beckman Coulter Inc)
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Fujifilm Holdings Corporation
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. NOVADIP Biosciences S.A.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. OmniSpirant Limited
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Thermo Fisher Scientific Inc
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Exosome Type (USD MN)
  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Market Sales By Geography (USD MN)
  • Non-cargo Market Sales By Geography (USD MN)
  • Analysis By Cell Source (USD MN)
  • HEK293 Cells Market Sales By Geography (USD MN)
  • MSCs Market Sales By Geography (USD MN)
  • Platelets Market Sales By Geography (USD MN)
  • Erythrocytes Market Sales By Geography (USD MN)
  • Natural Killer Cells Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Health Care Providers Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Exosome Technologies Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Exosome Technologies Report
  • Market Research Process
  • Market Research Methodology
  • Global Exosome Technologies Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Exosome Type
  • Market Attractiveness Analysis By Cell Source
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Exosome Type (USD MN)
  • Loaded Cargos (Peptide, SIRNA, mRNA, miRNA, Protein, Chemical, Others) Market Sales By Geography (USD MN)
  • Non-cargo Market Sales By Geography (USD MN)
  • Global Market Analysis By Cell Source (USD MN)
  • HEK293 Cells Market Sales By Geography (USD MN)
  • MSCs Market Sales By Geography (USD MN)
  • Platelets Market Sales By Geography (USD MN)
  • Erythrocytes Market Sales By Geography (USD MN)
  • Natural Killer Cells Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Therapeutics (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Cosmetics, Others) Market Sales By Geography (USD MN)
  • Diagnostics Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Health Care Providers Market Sales By Geography (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.